All In Biotech

Free tool

FAERS Monitor: Kineret

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103950 or its brand name (Kineret, Anakinra). Reports on generic versions are filed under their own applications.

Reports

16,900

Serious

11,721

69% of reports

Hospitalization

5,311

Death reported

1,576

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use5,297
  • drug ineffective4,355
  • condition aggravated1,743
  • pain1,603
  • rheumatoid arthritis1,556
  • arthralgia1,207
  • joint swelling1,192
  • pyrexia1,189
  • drug intolerance1,168
  • injection site pain1,047
  • rash996
  • nausea961
  • product dose omission issue940
  • infection921
  • vomiting884

Reports by year received

View as table
YearReports
2004118
200558
2006111
2007253
2008276
200988
201075
201180
2012109
2013117
2014107
2015186
2016563
2017864
20181,078
20191,586
20203,066
20211,624
20221,845
20231,210
20241,289
20251,182
20261,015

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,259 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal1,55617.316.523,651
drug intoleranceSignal1,16815.214.415,386
joint swellingSignal1,19212.411.712,432
infectionSignal9218.07.55,604
off label useSignal5,2977.67.431,310
condition aggravatedSignal1,7437.26.99,331
pyrexiaSignal1,1894.34.13,034
injection site painSignal1,0474.34.02,637
drug ineffectiveSignal4,3554.14.010,950
product dose omission issueSignal9404.03.72,124
arthralgiaSignal1,2073.63.42,326
painSignal1,6033.33.12,568
rashSignal9962.82.71,215
vomitingSignal8842.32.2693
nausea9611.51.4172

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.